Search Tag: Masimo

ICU Management

Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device

2016 13 Nov

Masimo (NASDAQ: MASI) has announced, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support Masimo’s efforts to develop a low-cost pulse oximeter for use in pneumonia screening in several low-resource areas outside the U.S. While still in development,... Read more

ICU Management

Philips & Masimo Sign Multi-Year Agreement in Patient Monitoring & Select Therapy Solutions

2016 07 Nov

Multi-year business partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies and Philips’ expertise in integrated patient monitoring and therapy solutionsBusiness partnership involves technology integration and marketing and sales cooperation in North America and certain markets in Asia and EuropeAgreement ends... Read more

ICU Management

Adam Mikkelson of Camber Capital Management Joins Masimo’s Board of Directors

2016 28 Oct

Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, announced today that Adam Mikkelson, Partner at Camber Capital Management, LLC, has been elected to Masimo’s Board of Directors.Mr. Mikkelson has been with Camber Capital Management, a healthcare-focused investment fund, since 2007. He has almost 15 years of experience... Read more

ICU Management

Study Investigates the Impact of Masimo Continuous SpHb® and PVI® on Anesthesia-Related Mortality

2016 24 Oct

Masimo (NASDAQ: MASI) has announced the findings of an abstract presented at the American Society of Anesthesiologists’ (ASA) Annual Meeting in Chicago. In the study, researchers at Hôpital Dupuytren, part of the Centre Hospitalier Universitaire of Limoges, France (CHU Limoges), investigated the clinical utility of noninvasive, continuous hemoglobin... Read more

ICU Management

Masimo Partners with Smile Train to Advance Safe Surgery

2016 30 Sep

Masimo (NASDAQ: MASI) has announced that it is partnering with Smile Train to help ensure the safety of patients undergoing cleft lip and/or palate surgery in low-resource settings around the world.Patient monitoring, including the use of pulse oximetry, is a key part of ensuring safe surgical care; however, in lower-resource settings essential monitoring... Read more

ICU Management

Masimo Announces a Special Worldwide Program for SpHb® Monitoring for Zika Virus Affected Areas

2016 29 Sep

Masimo (NASDAQ: MASI) has announced that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the cost of and increase access to Masimo’s continuous hemoglobin monitoring (SpHb®) solutions, shown to help clinicians reduce blood transfusions in both low... Read more

ICU Management

Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists

2016 29 Sep

Joint Initiative, “Safe Anaesthesia – ASAP,” Is to Improve Anesthesia Care in Low Resource CountriesMasimo (NASDAQ: MASI) has announced at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA). The four-year partnership, “Safe Anaesthesia... Read more

ICU Management

Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI®

2016 15 Sep

Masimo (NASDAQ: MASI) has announced the findings of a study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong. In the study, researchers at Cairo University in Egypt investigated the clinical utility of a Masimo SET® noninvasive, continuous measurement, PVI®.In the prospective study of 60 adult patients undergoing major... Read more

ICU Management

Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Red Blood Cell Transfusion

2016 09 Sep

 Masimo (NASDAQ: MASI) has announced that in a new study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong, researchers concluded that continuous and noninvasive hemoglobin monitoring using Masimo SpHb® may reduce excessive intraoperative red blood cell (RBC) transfusion.1In a retrospective review of 371 patients who underwent... Read more

ICU Management

Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry

2016 04 Aug

Masimo (NASDAQ: MASI) has announced the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, helps clinicians monitor cerebral oxygenation.O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended... Read more


Endorsed Companies